New Insights into the Pathophysiology of Type 2 Diabetes: A Review Article

New Insights into the Pathophysiology of Type 2 Diabetes: A Review Article

Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder characterized by chronic hyperglycemia resulting from insulin resistance, impaired insulin secretion, and dysregulated glucose homeostasis. Despite advances in understanding its clinical presentation and management, the underlying patho...

Full description

Saved in:

Bibliographic Details
Main Authors:	V S Jyothi Vybhavi, Milav Bhavsar, Jigar Gusani, Yashrajsinh Gohil, Nawal K Paul, Himaja Reddy Garlapati, Kirtika Shrivastava
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-06-01
Series:	Journal of Pharmacy and Bioallied Sciences
Subjects:	β-cell dysfunction epigenetics genetic factors gut microbiota insulin resistance low-grade inflammation type 2 diabetes mellitus
Online Access:	https://journals.lww.com/10.4103/jpbs.jpbs_1759_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Gut Microbiota Dysbiosis in Erectile Dysfunction: From Pathophysiology to Treatment Strategies
by: Aris Kaltsas, et al.
Published: (2025-01-01)

Interactions between the gut microbiome and DNA methylation patterns in blood and visceral adipose tissue in subjects with different metabolic characteristics
by: José Ignacio Martínez-Montoro, et al.
Published: (2024-12-01)

Associated factors and principal pathophysiological mechanisms of type 2 diabetes mellitus
by: Luyao Wang, et al.
Published: (2025-05-01)

Latest trends on interplay of autophagy, adipose tissue, and gut microbiota in obesity-related metabolic disorders
by: Claudette Butoyi, et al.
Published: (2025-06-01)

Network pharmacology-based insights into the role of gut microbiota metabolites in insulin resistance
by: Bing Xiao, et al.
Published: (2025-06-01)

Naringenin as a neurotherapeutic agent in Alzheimer’s disease: epigenetic signatures, gut microbiota alterations, and molecular neuroprotection
by: Zhenzhen Lai, et al.
Published: (2025-08-01)

Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases
by: Qihong Zhang, et al.
Published: (2025-12-01)

The Role of the Gut Microbiota in Heart Failure: Pathophysiological Insights and Future Perspectives
by: Francisco Epelde
Published: (2025-04-01)

influence of gut microbiota on the progression of Type 2 Diabetes
by: Lysandro Pinto Borges, et al.
Published: (2024-04-01)

Therapeutic Horizons: Gut Microbiome, Neuroinflammation, and Epigenetics in Neuropsychiatric Disorders
by: Shabnam Nohesara, et al.
Published: (2025-07-01)

Gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration
by: Menghan Zhang, et al.
Published: (2025-12-01)

Gut dysbiosis narrative in psoriasis: matched-pair approach identifies only subtle shifts correlated with elevated fecal calprotectin
by: Bayazit Yunusbayev, et al.
Published: (2025-01-01)

A retrospective study on blood microbiota as a marker for cognitive decline: implications for detecting Alzheimer’s disease and amnestic mild cognitive impairment in Republic of Korea
by: Youngchan Park, et al.
Published: (2025-04-01)

Impact of fracture fixation surgery on cognitive function and the gut microbiota in mice with a history of stroke
by: Lu Yu, et al.
Published: (2025-02-01)

Effect of perioperative probiotic intervention on postoperative cognitive dysfunction in elderly patients: a randomized double- blinded and placebo-controlled trial
by: Sunan Gao, et al.
Published: (2025-06-01)

MIND diet score and its association with metabolic dysfunction-associated steatotic liver disease and gut microbiota profiles: a cross-sectional study
by: Shengbo Yang, et al.
Published: (2025-08-01)

High Protein Diet Contributes to Insulin Resistance in Mice via Shaping Gut Microbiota
by: Yuhui Li, et al.
Published: (2025-06-01)

Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis
by: D. V. Garbuzenko
Published: (2022-10-01)

Alterations in fecal microbiota composition and cytokine expression profiles in adolescents with depression: a case-control study
by: Yiwen Cheng, et al.
Published: (2025-04-01)

β-ionone prevents dextran sulfate sodium-induced ulcerative colitis and modulates gut microbiota in mice
by: Jingjing Fang, et al.
Published: (2024-10-01)

A critical review on the impacts of β-glucans on gut microbiota and human health
by: Great Iruoghene Edo, et al.
Published: (2025-06-01)

Interaction between the inflammasome and commensal microorganisms in gastrointestinal health and disease
by: Daisuke Watanabe, et al.
Published: (2021-10-01)

The Effect of Maternal Diet and Lifestyle on the Risk of Childhood Obesity
by: Edyta Łuszczki, et al.
Published: (2024-11-01)

From bench to bed: deep insights the tacrolimus-induced diabetes and gut microbiota dysbiosis
by: Yuting Han, et al.
Published: (2025-08-01)

Palmitoleic acid on top of HFD ameliorates insulin resistance independent of diacylglycerols and alters gut microbiota in C57BL/6J mice
by: Qijian Liang, et al.
Published: (2024-03-01)

Role of sirtuins in obesity and osteoporosis: molecular mechanisms and therapeutic targets
by: Yikuan Du, et al.
Published: (2025-01-01)

The novel organoselenium compound 4aa ameliorates osteoporosis by modulating gut microbiota composition and fecal metabolite profiles
by: Chaoming Hu, et al.
Published: (2025-08-01)

Unraveling the gut microbiota’s role in PCOS: a new frontier in metabolic health
by: Caihong Li, et al.
Published: (2025-03-01)

Impact of gut microbiota on endometriosis: linking physical injury to mental health
by: Li Yuanyue, et al.
Published: (2025-07-01)

Epigenetic modifications of gut microbiota and their potential role in atherosclerosis
by: Shuang Guo, et al.
Published: (2025-07-01)

Parabacteroides distasonis promotes liver regeneration by increasing β-hydroxybutyric acid (BHB) production and BHB-driven STAT3 signals
by: Manlan Guo, et al.
Published: (2025-03-01)

Xylose-Oligosaccharide Alleviating Type 2 Diabetes in Mice via Reducing Blood Glucose, Oxidative Stress, Inflammation and Regulating Intestinal Microbiota
by: Xiangfei Li, et al.
Published: (2025-06-01)

Gut microbiota: an emerging target connecting polycystic ovarian syndrome and insulin resistance
by: Yufeng Mei, et al.
Published: (2025-03-01)

Epigenetic Mechanisms in Type-2 Diabetes Mellitus: A Narrative Review
by: Deenadhayalan Ashok, et al.
Published: (2025-01-01)

The role of microbiota dysbiosis in Parkinson’s disease: Pathophysiology and therapeutic opportunities
by: Shabnam Santos, et al.
Published: (2025-09-01)

Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease
by: Rachmad Anres Dongoran, et al.
Published: (2023-01-01)

Low leg fat mass is associated with low insulin sensitivity, inflammatory markers, and β-cell dysfunction in non-obese Japanese people
by: Satomi Minato-Inokawa, et al.
Published: (2025-07-01)

Optimized oxygen therapy improves sleep deprivation-induced cardiac dysfunction through gut microbiota
by: Shuqi Cai, et al.
Published: (2025-03-01)

Chlorogenic acid alleviates the intestinal barrier dysfunction and intestinal microbiota disorder induced by cisplatin
by: Ruiqi Tian, et al.
Published: (2025-03-01)

Zuojinwan ameliorates depressive-like behavior and gastrointestinal dysfunction in mice by modulating the FXR-bile acid-gut microbiota pathway
by: Dan Qiao, et al.
Published: (2025-06-01)